You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

Details for New Drug Application (NDA): 021143


✉ Email this page to a colleague

« Back to Dashboard


NDA 021143 describes TRIVAGIZOLE 3, which is a drug marketed by Taro and is included in one NDA. It is available from six suppliers. Additional details are available on the TRIVAGIZOLE 3 profile page.

The generic ingredient in TRIVAGIZOLE 3 is clotrimazole. There are eleven drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the clotrimazole profile page.
Summary for 021143
Tradename:TRIVAGIZOLE 3
Applicant:Taro
Ingredient:clotrimazole
Patents:0
Pharmacology for NDA: 021143
Medical Subject Heading (MeSH) Categories for 021143
Suppliers and Packaging for NDA: 021143
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TRIVAGIZOLE 3 clotrimazole CREAM;VAGINAL 021143 NDA Walgreen Company 0363-2062 0363-2062-01 1 TUBE, WITH APPLICATOR in 1 CARTON (0363-2062-01) / 21 g in 1 TUBE, WITH APPLICATOR
TRIVAGIZOLE 3 clotrimazole CREAM;VAGINAL 021143 NDA AmerisourceBergen 24385-110 24385-110-09 1 TUBE, WITH APPLICATOR in 1 CARTON (24385-110-09) / 21 g in 1 TUBE, WITH APPLICATOR

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:CREAM;VAGINALStrength2%
Approval Date:Apr 12, 2000TE:RLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.